Plasma Neurodegeneration and AD Biomarkers Identify Populations With Rapid Cognitive Decline

GSA 2025 Abstract

Abstract

Predicting rapid cognitive decline is valuable for patient counseling and targeting clinical trials to slow down this rate of decline.

The paper

Coresh J, Pike J, Reed N et al.

GSA 2025 Abstract · 31 Dec 2025 · CC BY

Presented at GSA 2025

doi.org/10.1093/geroni/igaf122.211